iohexol has been researched along with Ovarian Neoplasms in 5 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fibrothecomas are the most common solid ovarian tumors and may undergo torsion." | 1.35 | Computed tomography appearance of ovarian fibrothecomas with and without torsion. ( Chen, CY; Mak, CW; Tzeng, WS, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nougaret, S | 1 |
| Lakhman, Y | 2 |
| Molinari, N | 1 |
| Feier, D | 1 |
| Scelzo, C | 1 |
| Vargas, HA | 1 |
| Sosa, RE | 1 |
| Hricak, H | 2 |
| Soslow, RA | 1 |
| Grisham, RN | 1 |
| Sala, E | 1 |
| O'Neill, AC | 1 |
| Somarouthu, B | 1 |
| Tirumani, SH | 1 |
| Braschi-Amirfarzan, M | 1 |
| Van den Abbeele, AD | 1 |
| Ramaiya, NH | 1 |
| Shinagare, AB | 1 |
| Mak, CW | 1 |
| Tzeng, WS | 1 |
| Chen, CY | 1 |
| Akin, O | 1 |
| Sohn, MJ | 1 |
| Zheng, J | 1 |
| Moskowitz, CS | 1 |
| Iyer, RB | 1 |
| Barakat, RR | 1 |
| Sabbatini, PJ | 1 |
| Chi, DS | 1 |
| Choi, HJ | 1 |
| Lee, JH | 1 |
| Kang, S | 1 |
| Seo, SS | 1 |
| Choi, JI | 1 |
| Lee, S | 1 |
| Park, SY | 1 |
5 other studies available for iohexol and Ovarian Neoplasms
| Article | Year |
|---|---|
CT Features of Ovarian Tumors: Defining Key Differences Between Serous Borderline Tumors and Low-Grade Serous Carcinomas.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma; Contrast Media; Female; Humans; Imaging, Three-Dimensiona | 2018 |
Patterns and Prognostic Importance of Hepatic Involvement in Patients with Serous Ovarian Cancer: A Single-Institution Experience with 244 Patients.
Topics: Aged; Contrast Media; Female; Humans; Iohexol; Liver Neoplasms; Middle Aged; Neoplasm Staging; Ovari | 2017 |
Computed tomography appearance of ovarian fibrothecomas with and without torsion.
Topics: Adolescent; Adult; Aged; Contrast Media; Diatrizoate; Female; Fibroma; Humans; Iohexol; Middle Aged; | 2009 |
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.
Topics: Contrast Media; Diatrizoate; Disease Progression; Fallopian Tube Diseases; Female; Humans; Iohexol; | 2012 |
Contrast-enhanced CT for differentiation of ovarian metastasis from gastrointestinal tract cancer: stomach cancer versus colon cancer.
Topics: Adult; Colonic Neoplasms; Contrast Media; Diagnosis, Differential; Female; Humans; Iohexol; Male; Mi | 2006 |